CSTL1: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: CSTL1

NCBI ID: G128817

CSTL1

CSTL1: A Potential Drug Target Or Biomarker for Various Diseases

CSTL1 (CSTL1 variant 1) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the CSTL1 family, which is known for its role in cell signaling and inflammation.

Recent studies have identified CSTL1 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because CSTL1 has been shown to play a role in the development and progression of these conditions, and may be involved in the regulation of key cellular processes that contribute to their development.

One of the key functions of CSTL1 is its role in the regulation of cell signaling pathways. CSTL1 has been shown to play a negative role in the signaling pathway that regulates cell growth and differentiation. This pathway is important for the development and maintenance of tissues and organs, and is often disrupted in diseases such as cancer.

In addition to its role in cell signaling, CSTL1 is also involved in the regulation of inflammation. CSTL1 has been shown to play a role in the regulation of immune responses, and has been implicated in the development of autoimmune diseases. This is because CSTL1 is involved in the production of pro-inflammatory cytokines, which can contribute to the inflammation that occurs in autoimmune diseases.

Another function of CSTL1 is its role in cell adhesion. CSTL1 is involved in the regulation of cell-cell adhesion, which is important for the development and maintenance of tissues and organs. This is a critical process that allows cells to stick together and form tissues, and is often disrupted in diseases such as cancer.

In conclusion, CSTL1 is a protein that is expressed in various tissues throughout the body, and is involved in the regulation of cell signaling pathways, inflammation, and cell adhesion. As a result, it is a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of CSTL1 in these conditions, and to develop effective treatments.

Protein Name: Cystatin Like 1

The "CSTL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CSTL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets